WuXi PharmaTech, New WuXi deal

WuXi has agreed to be acquired and taken private by Chairman and CEO Ge Li and an investor group for $46 per ADS, or $3.3 billion. The price represents a 16% premium to WuXi’s close of $39.50 on April 29, before the group’s proposal was announced. WuXi, an R&D and manufacturing services company, will become a wholly owned subsidiary of New WuXi. The deal is expected to close in 4Q15. ...